Page last updated: 2024-10-19

phytic acid and Alcaptonuria

phytic acid has been researched along with Alcaptonuria in 2 studies

Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.

Research Excerpts

ExcerptRelevanceReference
" This leads to the accumulation of homogentisic acid (HGA) and its oxidized/polymerized products in connective tissues, which in turn become characterized by the presence of melanin-like pigments (ochronosis)."3.76Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. ( Amato, L; Bernardini, G; Braconi, D; Cavallo, G; Laschi, M; Marcolongo, R; Millucci, L; Santucci, A; Spreafico, A, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spreafico, A2
Millucci, L2
Ghezzi, L1
Geminiani, M1
Braconi, D2
Amato, L2
Chellini, F1
Frediani, B1
Moretti, E1
Collodel, G1
Bernardini, G2
Santucci, A2
Laschi, M1
Marcolongo, R1
Cavallo, G1

Other Studies

2 other studies available for phytic acid and Alcaptonuria

ArticleYear
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:9

    Topics: Acetylcysteine; Alkaptonuria; Antioxidants; Ascorbic Acid; Cell Line; Chondrocytes; Cytokines; Human

2013
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:10

    Topics: Acetylcysteine; Alkaptonuria; Antioxidants; Ascorbic Acid; Cells, Cultured; Coumaric Acids; Homogent

2010